More importantly, Toda et al. found a significant correlation between KRAS mutational status and SLC1A5 expression based on tissue microarray, when elevated SLC1A5 levels were notably associated with tumour depth and vascular invasion in KRAS-mutant CRC cases [212]. The gene discussed is KRAS; the disease is neoplasm.